Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 3/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | HTR7 | P34969 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11113574 | 0.81 | GLA (0.59) | POLBTDP1ALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL9893024 | 0.81 | HCRTR1 (0.43) | POLBTDP1L3MBTL1CYP1A2KMT2A | |
| SCHEMBL16480425 | 0.81 | HRH3 (0.43) | TDP1ALDH1A1L3MBTL1 | |
| SCHEMBL4636834 | 0.81 | GAA (0.46) | POLBKMT2AMEN1 | |
| SCHEMBL10574183 | 0.81 | TDP1 (0.55) | POLBTDP1ALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL9891754 | 0.80 | POLB (0.50) | POLBTDP1ALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL16480398 | 0.80 | PTGER2 (0.38) | TDP1KMT2A | |
| SCHEMBL25416662 | 0.79 | ALDH1A1 (0.42) | ALDH1A1GFERKMT2AMEN1 | |
| SCHEMBL10131414 | 0.79 | CYP3A4 (0.41) | CYP3A4KMT2AMEN1 | |
| SCHEMBL22658820 | 0.79 | SLC6A2 (0.46) | TDP1ALDH1A1L3MBTL1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116422367-B | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2025-01-28 | — | — | CN | claimed |
| CN-116422367-A | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2023-07-14 | — | — | CN | claimed |
| CN-116422367-B | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2025-01-28 | — | — | CN | disclosed |
| US-20240051974-A1 | DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES | PURDUE RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | US | disclosed |
| CN-116422367-A | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2023-07-14 | — | — | CN | disclosed |
| US-8629157-B2 | Pyrrolidine compounds which modulate the CB2 receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-14 | — | — | US | disclosed |
| US-20120142677-A1 | Pyrrolidine Compounds Which Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142677-A1 | Pyrrolidine Compounds Which Modulate The CB2 Receptor | CNR2, CNR1, OPRL1 | POLB 2879/4885TDP1 4464/4885ALDH1A1 3279/4885 |
| US-20240051974-A1 | DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES | MAOB, BCAT2, AADAT | POLB 80/4885TDP1 2489/4885ALDH1A1 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.